Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Type 2 Diabetes with TZD or TZD+Metformin
NCT00099320Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2004
- Primary completion
- Aug 2005
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 3 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started May 2004; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00099320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099320.